New drug boosts fight against HIV, researchers find

A new drug that advances the fight against HIV has been found to work better than treatments currently on the market, research led by a University of Toronto and Toronto General Hospital scientist has revealed.

"In most trials where HIV drugs go head to head, they usually end with one being as equally effective as the other. This is the first time that one protease inhibitor drug combination has been found to work better than another in patients who haven't received treatment before," says Dr. Sharon Walmsley, associate professor of medicine at U of T and senior scientist at Toronto General Hospital, University Health Network. Walmsley is lead author of a paper to appear in the June 27 issue of The New England Journal of Medicine. "The new drug combination is superior in inhibiting the virus and it's easier for patients to take. We also found that patients did not develop resistance to the drug, a major factor in HIV treatment."

The human immunodefficiency virus is a type of retrovirus that attacks the body's immune system. An enzyme called the protease enables the HIV virus to mature and replicate itself. One class of anti-retroviral drugs used to treat HIV is protease inhibitors, which work by blocking the protease thereby halting the replication process. They are typically used in combination with another class of anti-retroviral agents called reverse transcriptase inhibitors that hamper an earlier stage of HIV replication.

In the double-blind trial, the researchers tested 653 HIV-infected adults from 13 countries who had not previously received anti-retroviral therapy. Walmsley and her colleagues tested the new drug (a lopinavir-ritonavir combination, which is essentially two protease inhibitors in one) against nelfinavir (the most common protease inhibitor used in Canada). Both sets of patients also received two other anti-HIV agents generally taken with protease inhibitors.

At the end of the 24- and 48-week periods, more patient

Contact: Janet Wong
University of Toronto

Page: 1 2 3

Related biology news :

1. Commercialization deal boosts hope for new sickle-cell drug
2. EC boosts European electron microscopy research
3. Bioreactor boosts chemical fermentation by 50 percent: study
4. New genomics tool boosts diabetes research
5. DHEA boosts growth rate of human neural stem cells
6. Marine scientists discover nutrient pollution boosts fungi, bacteria killing Caribbean reefs
7. Sleep boosts ability to learn language, University of Chicago researchers find
8. $13 million grant boosts breast cancer research
9. New national studies show combined hormone replacement therapy boosts stroke, dementia
10. Green tea boosts antimicrobial properties of toothpaste
11. Study boosts confidence in potential screening tool for Alzheimers disease

Post Your Comments:

(Date:11/23/2018)... , ... November 23, 2018 , ... ... Emeran Mayer, MD, Executive Director of the G. Oppenheimer Center for Neurobiology of ... scientists and doctors from around the world, Dr. Mayer will bring to uBiome ...
(Date:11/20/2018)... ... ... Thanks to its long-standing expertise in ID reader development and industrialization, Elyctis is ... now proposes a full range of readers able to satisfy all needs including usage ... by professionals either in a fixed location or on the move as well as ...
(Date:11/16/2018)... PHILLADELPHIA (PRWEB) , ... November 16, 2018 , ... ... Jr., P.G., was awarded the International Bottled Water Association’s (IBWA’s) IBWA/Shayron Barnes-Selby ... week. , IBWA’s Advocacy Award, named “The Selby” after longtime IBWA contributor Shayron ...
Breaking Biology News(10 mins):
(Date:11/5/2018)... ... 05, 2018 , ... USARAD Holdings Inc., the leading US ... healthcare VC firms announces at Distributed Health 2018 conference November 5-6 (Nashville, TN) ... and obtaining its first radiology interpretations, one of the first known true use ...
(Date:11/3/2018)... ... 01, 2018 , ... Come to Princeton Nov. 14 and ... Division of Clinical Compliance Evaluation, CDER, FDA will be presenting on using data ... should clinical research industry stakeholders keep in mind when implementing and managing risk-based ...
(Date:10/31/2018)... ... 30, 2018 , ... Myoscience, Inc. announced today that it ... Memphis, Tennessee. This study enrolled 125 patients and compares the effect of ... after total knee replacement surgery (TKA). , The Myoscience iovera° system is currently ...
(Date:10/31/2018)... ... 2018 , ... Today, the National Corn Growers Association (NCGA) announced the launch ... to find new and innovative uses of field corn. NineSigma is serving as the ... of corn and are on pace to produce the second largest crop ever. One ...
Breaking Biology Technology:
Cached News: